Trademark Overview
On Monday, May 11, 2026, a trademark application was filed for NXERA AQ with the United States Patent and Trademark Office. The USPTO has given the NXERA AQ trademark a serial number of 99816404. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 11, 2026. This trademark is owned by Nxera Pharma Co., Ltd.. The NXERA AQ trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical services; pharmaceutical advice and consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes; all of the aforesaid relating to drug discovery and use of G-protein-coupled receptors in the design and development of pharmaceutical products
Business management, organisation and administration in the field of chemical products, biological products, pharmaceuticals, design and development of drugs, drug discovery; business management, organisation and administration in the field of research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; retail and wholesale services connected with the sale of pharmaceuticals, biological products and chemical and biological preparations; database management; computer database management; collection and compilation of data; compilation and systemisation of information and data in computer databases; compilation of information and data relating to life sciences, chemical and biological drug discovery, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; data processing, systemisation and management; data processing serv...
Drug and pharmaceutical discovery services; bio-technology, pharmaceutical, chemical and medical testing, research, development, advice, consultancy and information services; research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; pharmaceutical research services in chemical and biological drug discovery and development; research and development services for identifying lead chemical compounds; examination and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for screening purposes; research, analysis and examination for identification of compounds through automated screening processes; research and development services in chemical and biological pharmaceutical development; ...
Software, application software, computer software, computer software platforms, artificial intelligence, generative artificial intelligence software, generative design software, deep learning software, neural networks software and machine learning software, large language models software, frontier models software, foundation models software, retrieval augmented generation trained models software, knowledge graphs software; computer software for accessing, browsing and searching online databases; computer software for searching, tracking, modelling, exploration and analysis of data; artificial intelligence software for searching, tracking, modelling, exploration and analysis of data; databases; computer databases; data banks; electronic databases; interactive databases; data processing software; all of the aforementioned being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design a...
